Background-Chronic, inappropriate (relative to dietary Na ϩ ) elevations in circulating aldosterone, such as occur in congestive heart failure, are accompanied by a proinflammatory vascular phenotype involving the coronary and systemic vasculature. An immunostimulatory state with activated peripheral blood mononuclear cells (PBMCs) 
I
n both humans and rats, inappropriate (relative to dietary Na ϩ ) elevations in circulating aldosterone are accompanied by a proinflammatory/fibrogenic vascular phenotype that involves intramural arteries of the heart and systemic organs. [1] [2] [3] [4] [5] In a rat model of aldosterone/salt treatment (ALDOST), the appearance of such vascular remodeling is Na ϩ -and time-dependent and is prevented by cotreatment with spironolactone, an aldosterone receptor antagonist, in either nondepressor or depressor dosage. 6 Lesions include ED1-positive monocytes/macrophages and CD4-positive lymphocytes that first invade the perivascular space of involved vessels at week 4 of ALDOST. 4, 7, 8 We have previously found evidence of oxidative/nitrosative stress in these inflammatory cells, including an activation of gp91 phox , an NADPH oxidase subunit, and the presence of 3-nitrotyrosine, a product of the reaction between nitric oxide and superoxide; activation of a redox-sensitive nuclear transcription factor-B; and upregulated mRNA expression of a proinflammatory mediator cascade regulated by nuclear transcription factor-B and which includes intercellular adhesion molecule-1, monocyte chemoattractant protein-1, and tumor necrosis factor-␣. 7 Cotreatment with an antioxidant 7 or with agents that negatively regulate the transcription of inflammatory response genes 9 is vasculoprotective in the setting of chronic mineralocorticoid excess.
Peripheral blood mononuclear cells (PBMCs) are activated weeks before the appearance of these vascular lesions. Included here is an increased production of H 2 O 2 by monocytes and lymphocytes and an upregulated, differential expression of genes for antioxidant defenses, CC and CXC chemokines and their receptors, such cytokines as interleukin-1␤, and lymphocyte activation. 10, 11 This immunostimulatory state appears in the absence of prior organ injury and therefore without apparent exposure to self-antigen. Its pathogenesis has been attributed to H 2 O 2 , which is known to act as an intracellular messenger to mimic antigen-antigen receptor binding. 12 
Methods

Animals
Eight-week-old male Sprague-Dawley rats (Harlan Sprague Dawley, Indianapolis, Ind) were used in this study. Five groups were studied: (1) untreated, unoperated age-/gender-matched rats, which served as controls; (2) 11 with a modification of the ratiometric method and the fluorescent molecular probes mag-fura-2 and fura-2 (Molecular Probes), respectively. Briefly, PBMCs were washed and suspended in RPMI 1640 media containing 0.1% bovine serum albumin (pH 7.4). For loading the probes, the cells were incubated with mag-fura-2/AM (10 mol/L) for Mg 2ϩ or fura-2/AM (5 mol/L) for Ca 2ϩ for 1 hour at 37°C. After being washed 3 times with fresh RPMI 1640 media, the cells were suspended in analysis buffer consisting of (in mmol/L) NaCl 140, KCl 5, CaCl 2 
PBMC Hydrogen Peroxide Production
Lymphocyte H 2 O 2 production was measured as reported previously. 11 Briefly, 0.1 mL of whole blood was incubated with 2,7-dichlorofluorescein diacetate (25 mol/L, Molecular Probes) for 45 minutes at 37°C. After red blood cells were lysed with FACS lysing solution (Becton Dickinson), leukocytes were suspended in PBS (pH 7.4) for single-cell flow cytometric analysis with a FACS Caliber flow cytometer (Becton Dickinson). Lymphocytes were discerned by the combination of low-angle forward-scattered and right-angle scattered laser light. Fluorescent emission at 510 to 550 nm was recorded with excitation at 488 nm.
Immunohistochemistry (3-Nitrotyrosine)
Coronal cryostat sections (6 m) were prepared, air-dried, fixed in 10% buffered formalin for 5 minutes, and washed in PBS for 10 minutes. Sections were then incubated with primary antibody against 3-nitrotyroxine at a dilution of 1:100 (Upstate Biotech) in PBS containing 1% BSA for 60 minutes. Sections were then washed in PBS for 10 minutes and incubated with IgG-peroxidase-conjugated secondary antibody (Sigma) with a dilution of 1:150, washed in PBS for 10 minutes, incubated with 0.5 mg/mL diaminobenzidine tetrahydrochloride 2-hydrate plus 0.05% H 2 O 2 for 10 minutes, and again washed in PBS. Negative control sections were incubated with secondary antibody alone, stained with hematoxylin, dehydrated, mounted, and examined by light microscopy. 7
Statistical Analysis
Values presented are meanϮSEM. Data were statistically analyzed by 1-way ANOVA. Significant differences between individual means were determined with the post hoc Bonferroni multiple comparison test, where significance was assigned to PϽ0.05.
Results
Clinical Observations
At weeks 1 and 2 ALDOST, animals were active, eating, and gaining weight at levels comparable to controls. Anorexia, lethargy, and failure to gain weight were seen at weeks 3 and 4. Rats in the 3 intervention groups receiving ALDOST plus either Mg 2ϩ -supplemented diet, CCB, or NAC did not appear as ill as those receiving ALDOST alone. This is reflected in their body weights, which were less than controls at weeks 3 and 4 but greater than in those with ALDOST alone (Table) 
Lymphocyte Hydrogen Peroxide Production
H 2 O 2 production rose progressively in PBMCs harvested from rats during weeks 1 to 4 ALDOST and was significantly greater than controls at weeks 2 to 4 ( Figure 3) . In response to the Mg 2ϩ -supplemented diet, lymphocyte H 2 O 2 production was increased at week 1 ALDOST but did not differ from controls at weeks 2 to 4. During cotreatment with amlodipine or NAC, lymphocyte production of H 2 O 2 was attenuated compared with ALDOST and was not different from controls.
Immunohistochemistry
Superoxide anions react with nitric oxide to form short-lived peroxynitrite and ultimately stable nitrotyrosine protein moieties. The expression of 3-nitrotyrosine, as detected by immunohistochemistry, was used as an in situ marker of oxidative/nitrosative stress in the heart ( Figure 4A ). In controls, 3-nitrotyrosine is expressed by coronary vascular endothelial and smooth muscle cells; it is not found in the perivascular space or in cardiomyocytes (panel A). In ALDOST rats, perivascular swelling and infiltration by inflammatory cells is seen surrounding intramural coronary arteries together with 3-nitrotyrosine labeling ( Figure 4B ). The Mg 2ϩ -supplemented diet or CCB attenuated the expansion of the perivascular space and cellular infiltration and the appearance of 3-nitrotyrosine staining ( Figure  4C and 4D) . NAC treatment completely prevented such vascular remodeling and appearance of 3-nitrotyrosine with ALDOST ( Figure 4E ).
Discussion
The present study yielded several major findings. First, the early and persistent reduction in PBMC [Mg 2ϩ ] i that accompanies ALDOST was attenuated by a Mg 2ϩ -supplemented diet and NAC but not by CCB. As we and others have previously reported, 10 14, 20, 21 and with mineralocorticoid administration in humans. 22 weeks. 25 Herein, we were able to prevent the fall in [Mg 2ϩ ] i that appears with ALDOST by a Mg 2ϩ -supplemented diet. A reduced activity of Mg 2ϩ -dependent Na ϩ /K ϩ -ATPase may be contributory to the observed rise in PBMC [Ca 2ϩ ] i . DOC/salt treatment augments the number of Ca 2ϩ channels and raises [Ca 2ϩ ] i in various cell populations. 29 An aldosterone-induced expression and increased activity of T-type Ca 2ϩ channels has been reported in adrenal cells, cardiomyocytes, and prostate epithelial cells and is blocked by spironolactone. 30 -32 Whether this occurs in PBMCs during ALDOST is unknown, but if so, it would enhance the transfer of extracellular Ca 2ϩ directly to mitochondria via the endoplasmic reticulum and would contribute to the induction of oxidative/nitrosative stress in these cells. Mibefradil, a dual T-and L-type CCB, inhibits the proliferation of stimulated PBMCs, 33 reduces leukocyte adhesion by interfering with integrin signaling, 34 and is organ protective in rat models of chronic mineralocorticoid/salt excess. 35, 36 In the present study, we found amlodipine, an L-type channel blocker, attenuates PBMC Ca 2ϩ loading and the appearance of coronary vascular lesions. Other dihydropyridine CCBs have proved to be organ protective in rats with chronic mineralocorticoid excess. 15, 16, 37 Lymphocytes are otherwise nonexcitable cells and are where the membrane potential of T cells is primarily determined by both voltage-and Ca 2ϩ -dependent K ϩ channels, whose behavior resembles voltage-dependent Ca 2ϩ channels. 38 Dihydropyridine CCBs inhibit Ca 2ϩ entry in lymphocytes via their influence on Ca 2ϩ -activated K ϩ channels. 38 Nonetheless, enhanced PBMC Ca 2ϩ entry occurs during ALDOST. We cannot discount a release of this cation from intracellular organelles. It has been reported that once present, oxygen and nitrogen metabolites can augment Ca 2ϩ entry via voltagedependent channels, 39 which is supported by our findings with NAC that abrogated PBMC Ca 2ϩ loading during ALDOST.
Our second major finding is the induction of oxidative/ nitrosative stress in PBMCs that accompanies increased [Ca 2ϩ ] i and which was evidenced by increased H 2 O 2 production in circulating lymphocytes. Additional evidence of oxidative/nitrosative stress is the immunohistochemical detection of 3-nitrotyrosine we found in monocytes and lymphocytes invading the perivascular space of intramural coronary arteries. Reactive oxygen species, such as H 2 O 2 , serve as intracellular messengers in activating transcription of inflammatory cells, thus promoting their proinflammatory behavior. 12, 40 We have previously reported on the early activation of PBMC transcriptome during ALDOST. This includes a differential expression of genes that encode an oxidative stress-inducible tyrosine phosphatase and such antioxidant defenses as superoxide dismutase and that are coupled to upregulated expression of proinflammatory genes and those in keeping with lymphocyte activation and autoreactivity. 10 have been reported in rodent and human platelets during chronic mineralocorticoid excess (inappropriate for dietary Na ϩ intake) and in rodent neutrophils in response to dietary Mg 2ϩ deficiency. 14, 22, 28 The proinflammatory phenotype seen with dietary Mg 2ϩ deficiency is prevented when such a diet is simultaneously made Ca 2ϩ -deficient. 23 A Mg 2ϩ -supplemented diet has been reported to attenuate endothelin-1 production by heart, aorta, and kidneys in rats receiving DOC/salt treatment. 41, 42 This calcitropic hormone produced by endothelial cells is also released by parathyroid glands in response to reduced serum ionized Ca 2ϩ . 43 Herein, we found cotreatment with a CCB to attenuate PBMC Ca 2ϩ loading during ALDOST. In blocking Ca 2ϩ entry, amlodipine attenuated H 2 O 2 production by these cells. Further evidence supporting the importance of Ca 2ϩ loading in leading to an altered PBMC redox state is derived from our previous findings with spironolactone cotreatment, which prevented the rise in [Ca 2ϩ ] i and induction of oxidative stress, including H 2 O 2 production, and attenuated the upregulation of transcriptome of the proinflammatory PBMC phenotype. 11 Our in vivo findings underscore the importance of an equilibrium between intracellular Mg 2ϩ and Ca 2ϩ in the generation of reactive oxygen and nitrogen species, which in physiologically relevant concentrations may represent a final common pathway in the activation of lymphocytes and monocytes. Left unbridled, marked increments in reactive oxygen and nitrogen intermediates would adversely affect cell survival.
Finally, interventions used in the present study either attenuated or abrogated the proinflammatory coronary vascular phenotype and the presence of 3-nitrotyrosine in invading inflammatory cells at 4 weeks of ALDOST. Sun et al 7 previously reported that cotreatment with either an antioxidant, pyrrolidine dithiocarbamate, or spironolactone abrogates the appearance of oxidative/nitrosative stress and the number of inflammatory cells that invade the coronary vasculature at week 4 of ALDOST. Several clinical trials support the efficacy of aldosterone receptor antagonism, together with treatment with an ACE inhibitor and diuretic, in the overall management of symptomatic heart failure, 44, 45 in which aldosteronism is accompanied by evidence of oxidative/nitrosative stress in plasma, PBMCs, and such diverse tissues as skeletal muscle and heart. 46 -50 An integral feature of this systemic disorder is a catabolic state with simultaneous loss of lean tissue, fat, and bone and which eventuates in a wasting syndrome termed cardiac cachexia. 51 We believe inappropriate chronic elevations in plasma aldosterone (relative to dietary Na ϩ ) contribute to this illness through an immunostimulatory state mediated by iterations in PBMC divalent cations and oxidative/nitrosative stress, a contention supported by findings of the present study.
